NAMS
NewAmsterdam Pharma Co N.V.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
NewAmsterdam Pharma Co N.V.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No other changes.
No other changes.
No thesis.
Annual filing, covered
10-K parsed · Feb 18 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 18 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Largest filed tie
0
filed ties
—
NewAmsterdam Pharma Co N.V.
19.91
+0.35 · +1.77%
post 19.91 +0.01%
| Manager | Value | % base | |
|---|---|---|---|
| Frazier Life Sciences | $613.0M | 14.55% | +6.76% |
| Capital World Investors | $414.5M | 9.84% | +10.10% |
| FMR | $350.4M | 8.32% | +17.95% |
| RA Capital Management | $323.7M | 7.68% | 0.00% |
| Fcpm III Services B.V. | $287.7M | 6.83% | −7.70% |
| Manager | Value | % base | |
|---|---|---|---|
| Frazier Life Sciences | $613.0M | 14.55% | +6.76% |
| Capital World Investors | $414.5M | 9.84% | +10.10% |
| FMR | $350.4M | 8.32% | +17.95% |
| RA Capital Management | $323.7M | 7.68% | 0.00% |
| Fcpm III Services B.V. | $287.7M | 6.83% | −7.70% |
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for NewAmsterdam Pharma Co N.V..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for NewAmsterdam Pharma Co N.V..
Tall tick = annual report · Source: EDGAR
Expected move
Inputsspot 20.95exp Nov 20ATM strike 20ATM straddle 2.60IV 76%